switching from semaglutide to retatrutide tirzepatide retatrutide: the complete transition guide 🧬 SEMAGLUTIDE vs TIRZEPATIDE vs

Optimal levels of reduce your risk of cardiovascular disease and diabetes, promotes weight loss, and enhances overall quality of life

Exenatide was the first GLP-1 agonist approved in 2005

doi:10.1186/s13023-019-1064-y

Patients who are less than 18 years old Pregnant or breastfeeding mothers BMI of 25 or lower Patients with hypersensitivity to semaglutide Patients with a history of pancreatitis, medullary thyroid carcinoma, or endocrine neoplasia syndrome Each patient reacts to weight loss medications differently

You cannot take a higher dosage 12mg/weekly

A., Riahi, F., Hajmohammadi, M., Tiznobeyk, Z., & Mousavinejad, M